• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Neoplasms, Unknown Primary

Neoplasms, Unknown Primary - 24 Studies Found

Terminated : Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site
: Carcinoma of Unknown Primary
: 2005-09-02
:
  • Drug: Carboplatin
  • Drug: Gemcitabine

Terminated : Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary
: Carcinoma
: 2005-08-02
:
  • Drug: cisplatin
  • Drug: gemcitabine

Completed : Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
: Carcinoma of Unknown Primary
: 2003-08-06
:
  • Drug: gemcitabine hydrochloride

Completed : Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
: Carcinoma of Unknown Primary
: 2002-10-03
: Radiation: radiation therapy
<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.